Senior insider sale
EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$17.09M
499.06K shares
What this filing means
KALIF ELIYAHU SHARON plans to sell 499.06K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $17.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/14/2026ACC: 0001973379-26-000177
Officer· EVP, Chief Financial Officer
Since Dec 2019
499.06K
Shares to sell
$17.09M
Approx. market value
153.25K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
SHARES FROM ROLLOVER
COMPENSATION
3/4/2026
23.25KSHARES FROM ROLLOVER
COMPENSATION
3/3/2026
110.67KSHARES FROM ROLLOVER
COMPENSATION
3/3/2026
19.33KTotal acquired153.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | SHARES FROM ROLLOVER COMPENSATION | 23.25K | — |
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 110.67K | — |
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 19.33K | — |
| Total | 153.25K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
345.81K
Market value
$11.63M
2/26/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
153.25K
Market value
$5.46M
5/14/2026
Total
Units
499.06K
Value
$17.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/26/2026 | 345.81K | $11.63M | — | Completed |
| Planned — Approximate Date | ||||
5/14/2026 | 153.25K | $5.46M | NYSE | Planned |
| Total | 499.06K | $17.09M | ||